SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-003899
Filing Date
2016-01-14
Accepted
2016-01-14 13:32:58
Documents
3
Period of Report
2015-12-23
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s102488_8k.htm 8-K 16657
2 EXHIBIT 10.1 s102488_ex10-1.htm EX-10.1 4984
3 GRAPHIC image_001.jpg GRAPHIC 4283
  Complete submission text file 0001615774-16-003899.txt   29035
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 161342517
SIC: 2836 Biological Products, (No Diagnostic Substances)